Hi! This is Dr. Michael DiMattina, Medical Director of Dominion Fertility in Arlington, Virginia.
"Our goal at Dominion Fertility is to get the highest pregnancy rates possible for our patients, at the least cost"
Our goal at Dominion Fertility is to get the highest pregnancy rates possible for our patients, at the least cost. We do that, in large part, by taking our embryos and freezing all the embryos, and then transferring the embryos outside of the stimulated IVF cycle. Research has shown, and our experience agrees, that by doing that, you get higher pregnancy rates than if you transfer the embryo in the same cycle that the stimulation was performed and the embryo produced.
Now, today, there is an article out in the journal called Reproductive BioMedicine Online, which did a cost analysis, which showed that it’s also cost effective. Not only do you get higher pregnancy rates, but it’s actually more cost effective. This study was done in Europe, and on average they saved over $2,000 per treatment cycle, because when you freeze the embryos you get a higher pregnancy rate compared to putting the embryos in fresh. There is no downside, no risk with that either.
The bottom line is they were able to get higher pregnancy rates because there were fewer embryo transfers necessary, and that decreased the cost significantly. Fast forward to where we are now in 2017. Dominion Fertility happens to be one of the premier IVF centers in the United States performing stimulated IVF. We perform IVF using preimplantation genetic screening in almost all of our patients. PGS allows us to basically discriminate which embryo is genetically normal, and then by replacing that embryo, we even further increase our pregnancy rates and further decrease the cost.
"Fewer transfers, higher pregnancy rates, better outcome-that’s Dominion Fertility."
Fewer transfers, higher pregnancy rates, better outcome-that’s Dominion Fertility. Now we have a cost analysis out of Europe that confirms that there is a huge advantage to freezing all the embryos and transferring them outside of the stimulated cycle. So, good news for our patients!
Happy New Year!
Dr. Michael DiMattina, Medical Director